Bone morphogenetic protein-2-derived osteogenic peptide promotes bone regeneration via osteoblastogenesis
OP5, a low-molecular-weight peptide with strong osteogenic potential, may be a viable alternative to BMP-2 for clinical bone regeneration, minimizing BMP2-associated adverse effects.
Authors
- Dong‐Won Lee (ORCID: https://orcid.org/0000-0003-1852-7989)
- Hye‐Eun Shim (ORCID: https://orcid.org/0000-0002-2940-4362)
- Bosun Kwon (ORCID: https://orcid.org/0000-0002-8585-2194)
- Ji‐Youn Hong (ORCID: https://orcid.org/0000-0003-1040-7077)
- Jong‐Bin Lee (ORCID: https://orcid.org/0000-0002-6800-4337)
- Jeong‐Ho Yun (ORCID: https://orcid.org/0000-0003-3929-4467)
- Sehee Kim (ORCID: https://orcid.org/0000-0003-1670-0047)
Institutions
- Gangneung–Wonju National University (KR)
- RBio (South Korea) (KR)
- Jeonbuk National University Hospital (KR)
- Kyung Hee University Dental Hospital (KR)
- Gangnam Severance Hospital (KR)
- Jeonbuk National University (KR)
Publication Details
- Journal
- Regenerative Therapy
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.reth.2025.09.006
- Citations
- 1
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.81